U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX6981285: GSM4119263: 420Input; Homo sapiens; ChIP-Seq
2 ILLUMINA (HiSeq X Ten) runs: 71.2M spots, 10.8G bases, 3.9Gb downloads

Submitted by: NCBI (GEO)
Study: The role of TCF7L2 rs290487 variant in hepatic glucose metabolism: an integrated analysis of clinical and multi-omics data
show Abstracthide Abstract
TCF7L2 rs290487 C allele increases diabetic risk in Chinese, however the mechanism remains unclear. We herein evaluated the role of rs290487 variant in hepatic glucose homeostasis by integrating clinical and multi-omics data (ChIP-seq, ATAC-seq, RNA-seq, and metabolomics) from CRISPR/Cas9 edited PLC-PRF-5 cell lines (C/C vs. C/T). In clinical cohort, C/C genotype was associated with higher insulin resistance index and higher incidence of hepatogenous diabetes as compared to C/T heterozygote and T/T homozygote genotypes. In liver cell lines, C/C-cells had enhanced glucose production and lower TCF7L2 mRNA and protein levels than C/T-cells. Moreover, C/C-cells presented specific binding affinity of TCF7L2 with genes involving glucose metabolism (e.g., PFKP and PPARGC1A), increased expression of gluconeogenetic genes with specific chromatin openness (e.g., PPARGC1A and HNF4A), and deregulation of metabolites (e.g., ß-D-Fructose 2,6-bisphosphate). In addition, diabetic status (high glucose and insulin) had a more potent effect on TCF7L2 expression than the genetic variant, indicating a significant role of environmental factors on gene expression and disease progression. This study provides a novel mechanism underlying the association between TCF7L2 rs290487 polymorphism and hepatic regulation of glucose homeostasis. Overall design: integrating clinical and multi-omics data (ChIP-seq, ATAC-seq, RNA-seq, and metabolomics) from CRISPR/Cas9 edited PLC-PRF-5 cell lines (C/C vs. C/T)
Sample: 420Input
SAMN13019753 • SRS5506128 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: HiSeq X Ten
Strategy: ChIP-Seq
Source: GENOMIC
Selection: ChIP
Layout: SINGLE
Construction protocol: RNA-Seq:Briefly, mRNA was purified from total RNA using poly-T oligo-attached magnetic beads. Double-stranded complementary DNAs were synthesized using random hexamer primer and M-MuLV Reverse Transcriptase (Invitrogen). The cDNAs were then fragmented. ATAC-Seq: 50,000 cells for each sample were pelleted by centrifugation and lysed in lysis buffer containing 0.1% NP40, 0.1% Tween 20 and 0.01% Digitonin to obtain nucleic. The nucleic pellets were treated with TruePrep DNA Library Prep Kit V2 for Illumina (Vazyme, TD501) according to manufacturer's protocols. Immediately following transposition, DNA fragments were purified with MinElute PCR Purification Kit (QIAGEN) and PCR amplified with primers including barcode for a total of 10-12 cycles. The resulting libraries were purified and assessed with Qubit 3 Fluorometer (Invitrogen) and Agilent 2100 Bioanalyzer (Agilent). CHIP-Seq: cells were harvested and fixed. Chromatin was isolated by adding Lysis Buffer (Active Motif), followed by homogenization with Dounce homogenizer. Soluble chromatin was quantified by Nanodrop 2000 (ThermoFisher Scientific). ChIP was performed using Dynabeads Protein G (ThermoFisher Scientific) and 4 μL antibody against TCF4/TCF7L2 (Catalog number 2569, Cell Signaling Technology) with 20-50 μg soluble chromatins. Rabbit IgG (Catalog number ab172730, Abcam) was used for negative control. The beads-antibody-chromatin complexes were washed using ChIP-IT Express Enzymatic (Active Motif) according to manufacturer's protocols. The chromatin was reverse cross linked overnight at 65°C, treated with RNase A and proteinase K, respectively. The DNA was cleaned up with QIAGEN MinElute PCR Purification Kit (QIAGEN). RNA-Seq:using the Illumina paired-end RNA-seq approach according to the standard protocol. ATAC-Seq:The libraries were sequenced on Illumina Hiseq XTen instrument (Illumina).Briefly, 50,000 cells for each sample were pelleted by centrifugation and lysed in lysis buffer containing 0.1% NP40, 0.1% Tween 20 and 0.01% Digitonin to obtain nucleic. The nucleic pellets were treated with TruePrep DNA Library Prep Kit V2 for Illumina (Vazyme, TD501) according to manufacturer's protocols. Immediately following transposition, DNA fragments were purified with MinElute PCR Purification Kit (QIAGEN) and PCR amplified with primers including barcode for a total of 10-12 cycles. The resulting libraries were purified and assessed with Qubit 3 Fluorometer (Invitrogen) and Agilent 2100 Bioanalyzer (Agilent). CHIP-Seq: ChIP-seq libraries were prepared using KAPA Hyper Prep Kit and sequenced on Illumina Hiseq XTen instrument.Briefly, cells were harvested and fixed. Chromatin was isolated by adding Lysis Buffer (Active Motif), followed by homogenization with Dounce homogenizer. Soluble chromatin was quantified by Nanodrop 2000 (ThermoFisher Scientific). ChIP was performed using Dynabeads Protein G (ThermoFisher Scientific) and 4 μL antibody against TCF4/TCF7L2 (Catalog number 2569, Cell Signaling Technology) with 20-50 μg soluble chromatins. Rabbit IgG (Catalog number ab172730, Abcam) was used for negative control. The beads-antibody-chromatin complexes were washed using ChIP-IT Express Enzymatic (Active Motif) according to manufacturer's protocols. The chromatin was reverse c ross linked overnight at 65°C, treated with RNase A and proteinase K, respectively. The DNA was cleaned up with QIAGEN MinElute PCR Purification Kit (QIAGEN).
Experiment attributes:
GEO Accession: GSM4119263
Links:
Runs: 2 runs, 71.2M spots, 10.8G bases, 3.9Gb
Run# of Spots# of BasesSizePublished
SRR1026786535,609,7615.4G1.9Gb2020-07-29
SRR1026786635,609,7615.4G2.1Gb2020-07-29

ID:
9183256

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...